Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study.

Filiaciones

Reitsamer H:

Department of Ophthalmology and Optometry, University Clinic Salzburg, SALK/Paracelsus Medical University, Salzburg, Austria

Vera V:

Department of Ophthalmology, Unidad Oftalmologica de Caracas, Caracas, Venezuela

Ruben S:

Department of Ophthalmology, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, UK

Au L:

Department of Eye Research, Manchester Royal Eye Hospital, Manchester, UK

Medical Academic Health Science Centre, University of Manchester, Manchester, UK

Vila-Arteaga J:

Hospital Universitario la Fe, Valencia, Spain

Teus M:

Hospital Universitario Principe de Asturias, Universidad de Alcalá, Madrid, Spain

Lenzhofer M:

Department of Ophthalmology and Optometry, University Clinic Salzburg, SALK/Paracelsus Medical University, Salzburg, Austria

Shirlaw A:

Allergan, an AbbVie Company, Marlow, UK

Bai Z:

Allergan, an AbbVie Company, Madison, NJ, USA

Balaram M:

Allergan, an AbbVie Company, Irvine, CA, USA

Stalmans I:

Department of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium